From innovation to legislation, the US audiology market is being shaped by cutting-edge technology from device makers and legislation from the Biden administration to get more hearing aids to those that need them.

Although near-term challenges have slowed growth in the market for left ventricular assist devices (LVADs), companies are developing new, less invasive VADs with improved pump designs to further improve patient outcomes and allow for a wider application of the therapy in treating heart failure. These next-generation VADs are fueling long-term optimism in the market for mechanical circulatory support, which remains one of the more attractive opportunities in the cardiovascular space.

Medtech start-ups are pioneering innovative device solutions for heart failure that they hope will end the vicious cycle of costly hospitalizations and declining patient health. Profiles of Calon-Cardio Technology, Cibiem, and DC Devices.

This Month's Profile Group: Medtech Start-Ups Aim To Reverse The Downward Spiral of Heart Failure, features profiles of BioVentrix, Calon Cardio-Technology, Cibiem, DC Devices, and LoneStar Heart. Plus these Start-Ups Across Health Care: Dialog Devices, Lumena Pharmaceuticals, and STAT-Diagnostica.